Participants 13 30 3
posterior uveitis
Participants 117 261 3
To evaluate the safety and efficacy of 0.59-mg and 2.1-mg fluocinolone acetonide (FA) intravitreous implants in noninfectious posterior uveitis.
Participants 269 445 9
A 3-year, multicenter, randomized, historically controlled trial of the 0.59-mg FA intravitreous implant in 110 patients and the 2.1-mg FA intravitreous implant in 168 patients
Participants 1350 1396 3
subjects with noninfectious posterior uveitis.
